正商实业(00185.HK)附属以2.9亿人币收购河南省两幅地块
正商实业(00185.HK)公布,旗下间接全资附属公司河南沐歌分别以代价1.74亿元人民币(下同)及1.16亿元成功投得地块I及地块II。
地块I位於河南省新郑市薜店镇世纪大道东侧、樱花路南侧,总占地面积5.05万平方米,地块II位於河南省新郑市薜店镇莲花路北侧、神州路西侧,总占地面积3.37万平方米,两幅地块均指定为住宅用途,使用年限为70年。
公司相信,收购事项符合集团扩大於中国河南省及其他第一、第二线城市发展的策略,乃属具收益性质的交易,且於日常及一般业务过程中按正常商业条款进行,属公平合理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.